Crystagen (EDP) is a synthetic tripeptide bioregulator associated with thymic peptide research. It has been studied in research settings for its role in immune cell signaling pathways and gene expression–related regulatory mechanisms, including processes involving lymphocyte activity and cellular differentiation.